Analysis Date: 2025-12-11T10:42:02.694892 Trading Period: 2025-12-08 to 2025-12-19
Company: Tonix Pharmaceuticals Holding Corp. Sector: Healthcare | Industry: Biotechnology Current Price: $19.75 Market Cap: $232,586,704 Beta: 1.83 Avg Volume: 879,170 P/E Ratio: 0.07 Website: https://www.tonixpharma.com
Description: Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults. Its portfolio focuses on central nervous system disorders, as well as immunology, infectious disease, and rare disease product candidates. The company's products pipeline include TNX-102 SL (cyclobenzaprine HCl sublingual tablet), for...
Action: STRONG AVOID Confidence: 20.0/100 Position Size: 0.0% of portfolio
Rationale: Unfavorable conditions (composite: 34.2/100, risk: EXTREME, red flags: 1).
Passed Filters: ✓ Yes Notes: Passed all screening filters
Composite Score: 3.20/5.0 Percentile Rank: 100%
Factor Scores:
Setup Score: 2/8 Setup Notes: Strong uptrend (above both SMAs)
Price Levels:
Momentum & Volume:
Technical Risk Factors:
Risk Level: EXTREME Confidence: 10.0/100 Total Red Flags: 1 Earnings Risk: No
Critical Issues:
This report is generated by PM automated research system. Always perform your own due diligence before trading.